Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
16,517 results
- Joyful Parenting Pilot Project RCT Study: Complete Statistical AnalysisIndependent statistical analysis of Joyful Parenting Pilot Project RCT Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03282071).
- JPN ATO OLEIndependent statistical analysis of A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Jugular Venous Flow Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Jugular Venous Flow Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002494).
- Jump StartIndependent statistical analysis of Jump Start Shared Medical Appointments for Diabetes With Weight Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01973972).
- Junctional AV Ablation in CRT-D: JAVA-CRT: Complete Statistical AnalysisIndependent statistical analysis of Junctional AV Ablation in CRT-D: JAVA-CRT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02946853).
- JUNGLEIndependent statistical analysis of Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- JUNIPERIndependent statistical analysis of Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- JUNIPERIndependent statistical analysis of Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144: primary endpoint results, effect estimate with confidence interval, sample-size…
- Juno Perth Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Juno Perth Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02317042).
- Just Kwit: Mobile Intervention for Tobacco Cessation: Complete Statistical AnalysisIndependent statistical analysis of Just Kwit: Mobile Intervention for Tobacco Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03538678).
- K-PASSIndependent statistical analysis of Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Kaletra and Viread in Antiretroviral Naïve Patients: Complete Statistical AnalysisIndependent statistical analysis of Kaletra and Viread in Antiretroviral Naïve Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00679926).
- KALMARIndependent statistical analysis of Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01068873).
- KAMELEONIndependent statistical analysis of A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors: primary endpoint results, effect estimate with confidence…
- Kangaroo Mother Care to Prevent Hypothermia in Term Infants: Complete Statistical AnalysisIndependent statistical analysis of Kangaroo Mother Care to Prevent Hypothermia in Term Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02189759).
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD: Complete Statistical AnalysisIndependent statistical analysis of Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KAPTIndependent statistical analysis of Ketamine for Acute Pain Management After Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04129086).
- KAREIndependent statistical analysis of Ketamine for Reduction of Alcoholic Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02649231).
- KARISMA2Independent statistical analysis of KARISMA2, a randomized phase 2 trial evaluating low-dose tamoxifen for mammographic density reduction, including its non-inferiority framework, Wald testing, multiplicity adjustment, results, safety, and statistical interpretation.
- KARMA-depIndependent statistical analysis of Ketamine as an Adjunctive Therapy for Major Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03256162).
- KASTPainIndependent statistical analysis of Knee Arthroplasty Pain Coping Skills Training (KASTPain): A Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01620983).
- KATE2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced…
- KavaPKIndependent statistical analysis of Biomarker Changes and Anxiolytic Effects-Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04565145).
- KAVIAR Study – Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures: Complete Statistical AnalysisIndependent statistical analysis of KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03919799).
- KEEP-PIndependent statistical analysis of Trial of KEEP-P, a Preventive Intervention for Foster Preschoolers (KEEP-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03106636).
- KEEPS MDBHASIndependent statistical analysis of KEEPS Mammographic Density And Breast Health Ancillary Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02524561).
- KEEPsAKE 1Independent statistical analysis of A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease…
- KEM-VOCIndependent statistical analysis of Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02434939).
- KET-ROIndependent statistical analysis of KET-RO Plus RO DBT for Treatment Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06138691).
- Ket-RSIIndependent statistical analysis of Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KETAFAPIndependent statistical analysis of Ketamine For Acute Treatment of Pain in Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02306759).
- KETAMINEIndependent statistical analysis of Administration of Ketamine to Prevent the Post-operative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00210210).
- Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy: Complete Statistical AnalysisIndependent statistical analysis of Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02643979).
- Ketamine and Propofol for Upper Endoscopy: Complete Statistical AnalysisIndependent statistical analysis of Ketamine and Propofol for Upper Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02295553).
- Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02106325).
- Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study: Complete Statistical AnalysisIndependent statistical analysis of Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ketamine for Acute Migraine in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Ketamine for Acute Migraine in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02697071).
- Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03431285).
- Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ketamine for Treatment of MS Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Ketamine for Treatment of MS Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03500289).
- Ketamine in Borderline Personality Disorder: Complete Statistical AnalysisIndependent statistical analysis of Ketamine in Borderline Personality Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395314).
- Ketamine in the Treatment of Depression: Complete Statistical AnalysisIndependent statistical analysis of Ketamine in the Treatment of Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01558063).
- Ketamine Patient-Controlled Analgesia for Acute Pain: Complete Statistical AnalysisIndependent statistical analysis of Ketamine Patient-Controlled Analgesia for Acute Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02062879).
- Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): Complete Statistical AnalysisIndependent statistical analysis of Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ketamine Treatment Effects on Synaptic Plasticity in Depression: Complete Statistical AnalysisIndependent statistical analysis of Ketamine Treatment Effects on Synaptic Plasticity in Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04091971).
- Ketoconazole Foam 2% for the Treatment of Versicolor: Complete Statistical AnalysisIndependent statistical analysis of Ketoconazole Foam 2% for the Treatment of Versicolor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00830388).
- Ketogenic Diet (KD) in Alcoholism: Complete Statistical AnalysisIndependent statistical analysis of Ketogenic Diet (KD) in Alcoholism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255031).
- Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or Older: Complete Statistical AnalysisIndependent statistical analysis of Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or Older: primary endpoint results, effect estimate with confidence interval,…
- KetoPltAggIndependent statistical analysis of IV Ketorolac on Platelet Function Post-Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03805607).